EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Phyto-Lipid Polymeric Hybrid Nanoparticles Enable Anti-inflammatory Immunomodulation through Corona-Mediated Cytokine Sequestration

Gargi Y Digholkar, Apurva Rajesh Pardeshi, Junsik J Sung, Ryan M Pearson iD

ACS Omega · 03.11.2026 · 11 (43) · 67065-67078

DOI: 10.1021/acsomega.6c07501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 22.10.2026. Verfasst von Gargi Y Digholkar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N. Pine Street, Baltimore, Maryland 21201, United States. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic inflammation and sepsis-associated cytokine storm remain major clinical challenges because current therapeutic strategies have limited ability to inhibit pre-established pro-inflammatory immune responses. Here, we report the engineering of a bioinspired phyto-lipid polymeric hybrid nanoparticle platform (PLPH-NP) that integrates maca-derived lipid NP (MDNP), isolated from Lepidium meyenii Walp., with immunomodulatory poly(lactic acid) (PLA) NP to attenuate systemic inflammation through complementary biomolecular corona-mediated cytokine sequestration and anti-inflammatory immunomodulatory mechanisms. PLPH-NP were fabricated by coating PLA NP cores with bioactive lipids isolated from MDNP through thin-film hydration and extrusion. Physicochemical characterization confirmed a distinct core–shell architecture with a zeta potential profile characteristic of the MDNP lipid interface, and particles remained colloidally stable under physiological conditions. In vitro studies using primary bone marrow-derived macrophages demonstrated efficient, time-dependent internalization of PLPH-NP and confirmed low cytotoxicity at therapeutically relevant concentrations. Functionally, PLPH-NP outperformed both MDNP and PLA NP individual controls, achieving superior suppression of LPS-induced NF-κB activation and significantly greater reductions in pro-inflammatory cytokine secretions. Cell-free sequestration assays further demonstrated that the hybrid architecture retained cytokine sequestration activity comparable to MDNP, confirming preservation of this key functional property, while PLA nanoparticles provided complementary suppression of innate immune signaling, together enabling a dual-action anti-inflammatory mechanism. In a murine LPS-induced endotoxemia rescue model, PLPH-NP efficiently suppressed IL-6, TNF-α, and IFN-β secretions in the plasma, while simultaneously mitigating inflammation-associated organ damage compared to controls. These results establish PLPH-NP as a modular, biologically inspired nanotherapeutic platform that addresses persistent barriers in immunomodulatory therapy for systemic inflammation.

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 N. Pine Street, Baltimore, Maryland 21201, United States.
  • Department of Pharmaceutical and Administrative Sciences, College of Pharmacy and Health Sciences Western New England University, 1215 Wilbraham Road, Springfield, Massachusetts 01119, United States.
  • Department of Microbiology and Immunology, University of Maryland School of Medicine, 685 W. Baltimore Street, Baltimore, Maryland 21201, United States.
  • Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, 22 S. Greene Street, Baltimore, Maryland 21201, United States.

ORCID-Profile: Ryan M Pearson

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Cancer Institute
  • National Institute of Allergy and Infectious Diseases
  • University of Maryland
  • Maryland Department of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Digholkar, G. Y., Pardeshi, A. R., Sung, J. J., & Pearson, R. M. (2026). Phyto-Lipid Polymeric Hybrid Nanoparticles Enable Anti-inflammatory Immunomodulation through Corona-Mediated Cytokine Sequestration. ACS Omega, 11(43), 67065-67078. https://doi.org/10.1021/acsomega.6c07501

Vancouver

Digholkar GY, Pardeshi AR, Sung JJ, Pearson RM. Phyto-Lipid Polymeric Hybrid Nanoparticles Enable Anti-inflammatory Immunomodulation through Corona-Mediated Cytokine Sequestration. ACS Omega. 2026;11(43):67065-67078. doi:10.1021/acsomega.6c07501

BibTeX
@article{Digholkar2026,
  author = {Digholkar, Gargi Y and Pardeshi, Apurva Rajesh and Sung, Junsik J and Pearson, Ryan M},
  title = {Phyto-Lipid Polymeric Hybrid Nanoparticles Enable Anti-inflammatory Immunomodulation through Corona-Mediated Cytokine Sequestration},
  journal = {ACS Omega},
  year = {2026},
  volume = {11},
  number = {43},
  pages = {67065--67078},
  doi = {10.1021/acsomega.6c07501}
}
Kostenlos starten →